DRL inks pact with Eris Life to divest certain non-brands
Dr. Reddy's Laboratories (DRL) announced that along with its subsidiaries it has signed a deal to divest certain non-core brands of the company in the dermatology segments to Eris Lifesciences for Rs 275 crore.